Announced Thu, 8 Oct, 2026 · 13:01 IST
Wanbury files new DMFs in South Africa, Philippines, Singapore; gets EDQM and TGA nods
WANBURY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹197.36
prior close
₹198.47
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.1-0.0-0.9——————————
Up moveDown movePending
AI summary
Wanbury Limited has filed a new Drug Master File (DMF) in South Africa for Tramadol HCl API, and DMFs in Philippines and Singapore for Metformin HCl API. The company also added vendors for key starting materials for its Paroxetine HCl API and received approval from EDQM (European Directorate for the Quality of Medicines). Additionally, TGA Australia accepted its compliance report, allowing continued supply of APIs to the Australian market.
Likely market impact
Positive - regulatory approvals and new market filings expand export opportunities and support revenue growth in international markets.